Home › Kanser (lahat ng uri) › New Mexico › Albuquerque
Pag-aaral pangklinika para sa Kanser (lahat ng uri) sa Albuquerque, NM
14 pag-aaral para sa Kanser (lahat ng uri) ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Albuquerque (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Nagre-recruitPhase 3
- University of New Mexico Cancer Center, Albuquerque
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Nagre-recruitPhase 2
- Lovelace Medical Center - Saint Joseph Square, Albuquerque
- Presbyterian Kaseman Hospital, Albuquerque
- The University of New Mexico Comprehensive Cancer Center, Albuquerque
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Nagre-recruitPhase 2
- University of New Mexico, School of Medicine, Albuquerque
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
Nagre-recruitPhase 1/2
- Research Site, Albuquerque
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Nagre-recruitPhase 3
- University of New Mexico Comprehensive Cancer Center, Albuquerque
Project: Every Child for Younger Patients With Cancer
Nagre-recruitObservasyonal na pag-aaral
- Presbyterian Hospital, Albuquerque
- University of New Mexico Cancer Center, Albuquerque
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Nagre-recruitPhase 3
- University of New Mexico Cancer Center, Albuquerque
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Nagre-recruitPhase 2
- 292, Albuquerque
Molecular Genetics Studies of Cancer Patients and Their Relatives
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Lovelace Medical Center-Downtown, Albuquerque
- New Mexico Oncology Hematology Consultants, Albuquerque
- Presbyterian Kaseman Hospital, Albuquerque
Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing
Nagre-recruit
- University of New Mexico Comprehensive Cancer Center, Albuquerque
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Albuquerque
A Prospective Registry to Enable Collection of Standardized Routine Care Oncology Patient Data
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- New Mexico Oncology Hematology Consultants, Albuquerque
Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
Nagre-recruitObservasyonal na pag-aaral
- University of New Mexico Comprehensive Cancer Center, Albuquerque
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Nagre-recruit
- Lovelace Medical Centre-Saint Joseph Square, Albuquerque
- Lovelace Women's Hospital, Albuquerque
Pag-aaral para sa Kanser (lahat ng uri) sa ibang lungsod
- Houston, TX121 pag-aaral
- New York City, NY109 pag-aaral
- Boston, MA85 pag-aaral
- Los Angeles, CA74 pag-aaral
- Nashville, TN65 pag-aaral
- Philadelphia, PA59 pag-aaral
- Washington, DC58 pag-aaral
- Durham, NC58 pag-aaral
- Chicago, IL51 pag-aaral
- Atlanta, GA49 pag-aaral
- Seattle, WA49 pag-aaral
- Arlington, VA48 pag-aaral
Iba pang pag-aaral sa Albuquerque
- Non-Small Cell Lung Cancer18 pag-aaral
- Kanser sa Suso17 pag-aaral
- Kanser sa Ovary15 pag-aaral
- Kanser sa Baga14 pag-aaral
- Metastatic Cancer12 pag-aaral
- Kanser ng Endometrium12 pag-aaral
- Type 2 Diabetes11 pag-aaral
- Sakit sa Puso at Ugat ng Dugo10 pag-aaral
- Melanoma9 pag-aaral
- Acute Myeloid Leukemia9 pag-aaral
- Kanser sa Prostate9 pag-aaral
- Chronic Kidney Disease8 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.